Pelthos Therapeutics Unveils 2025 Financials, Charting Course for Future Innovations
A Strategic Handshake: Astria Therapeutics Licenses Key Drug to BioCryst, Redefining Focus
Cidara Therapeutics Skyrockets as Morgan Stanley Elevates Rating to 'Overweight'